十大电竞开盘

Other Plans and Options
  • (-0.14%) Nav, as on 09-09-2022

  • Previous Nav

  • Net Change on 09-09-2022

  • 十大电竞(广州)最新版登录正规 Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option -0.63 4.80 -9.23 22.42 15.33 7.66
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 -9.23 22.42 15.33 2.50 519.10
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 -10.91 24.31 17.27 1.98 4,587.75
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 -7.69 24.45 12.49 2.18 1,675.44
UTI Healthcare Fund - Regular Plan - IDCW Aug 25, 1999 -12.04 23.07 13.05 2.39 713.11
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 -9.23 22.42 15.33 2.50 519.10

Fund Holdings as on 31-August-2022

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • DR REDDYs LABORATORIES LTD

  • CIPLA LTD

  • APOLLO HOSPITALS ENTERPRISE LTD

  • ALKEM LABORATORIES LTD

  • FORTIS HEALTHCARE LTD

  • IPCA LABORATORIES LTD

  • LUPIN LTD

  • J.B.CHEMICALS & PHARMACEUTICALS LTD

  • AUROBINDO PHARMA LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • DIVI LABORATORIES LTD

  • FDC LTD

  • PROCTER & GAMBLE HEALTH LTD

  • INDOCO REMEDIES LTD

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

  • ABBOTT INDIA LTD

  • NARAYANA HRUDAYALAYA LTD

  • GLAND PHARMA LTD

  • AJANTA PHARMA LTD

  • A) REPO

  • GLENMARK PHARMACEUTICALS LTD

  • ICICI LOMBARD GENERAL INSURANCE CO. LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • SANOFI INDIA LTD

  • KRSNAA DIAGNOSTICS LTD

  • TORRENT PHARMACEUTICALS LTD

  • NET CURRENT LIABILITIES

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

View More

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund . It was launched on 28-Dec-2015 and currently has an AUM of ₹519.10 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended down ₹-0.02 (-0.14%) yesterday to ₹16.4056 .

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

+91 (22) 66578282
kiran@tataamc.com
+91 (22) 22613782
英雄联盟竞猜赛事在线永久 fifa电竞(长春)手游外围1.4.10 gtv电竞比赛数据 大圣电竞数据APP v2.3 esg电竞比分详情 lpl电竞比赛排名官网